- Home
- SOL vs RCEL Comparison
SOL vs RCEL Comparison
Compare SOL & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOL
- RCEL
- Stock Information
- Founded
- SOL 2005
- RCEL N/A
- Country
- SOL United States
- RCEL United States
- Employees
- SOL N/A
- RCEL N/A
- Industry
- SOL Semiconductors
- RCEL Medical/Dental Instruments
- Sector
- SOL Technology
- RCEL Health Care
- Exchange
- SOL Nasdaq
- RCEL Nasdaq
- Market Cap
- SOL 98.5M
- RCEL 114.3M
- IPO Year
- SOL 2008
- RCEL N/A
- Fundamental
- Price
- SOL $1.79
- RCEL $3.76
- Analyst Decision
- SOL Strong Buy
- RCEL Buy
- Analyst Count
- SOL 2
- RCEL 5
- Target Price
- SOL $4.50
- RCEL $11.75
- AVG Volume (30 Days)
- SOL 154.1K
- RCEL 201.1K
- Earning Date
- SOL 11-14-2025
- RCEL 11-06-2025
- Dividend Yield
- SOL N/A
- RCEL N/A
- EPS Growth
- SOL N/A
- RCEL N/A
- EPS
- SOL N/A
- RCEL N/A
- Revenue
- SOL $71,226,000.00
- RCEL $72,401,000.00
- Revenue This Year
- SOL N/A
- RCEL $19.96
- Revenue Next Year
- SOL $45.37
- RCEL $33.43
- P/E Ratio
- SOL N/A
- RCEL N/A
- Revenue Growth
- SOL N/A
- RCEL 20.59
- 52 Week Low
- SOL $1.04
- RCEL $3.35
- 52 Week High
- SOL $2.30
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- SOL 38.62
- RCEL 41.52
- Support Level
- SOL $1.76
- RCEL $3.51
- Resistance Level
- SOL $1.85
- RCEL $4.09
- Average True Range (ATR)
- SOL 0.04
- RCEL 0.26
- MACD
- SOL -0.01
- RCEL 0.06
- Stochastic Oscillator
- SOL 22.14
- RCEL 55.78
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has globalised Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. Majority of revenue is From Electricity Generation. The company operates in China, USA, Germany, UK, Spain, France, Poland, Italy, Hungary, Luxembourg. Majority of revenue is from Italy.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.